Pharmacoeconomics of mobilization
Panel discussion on immune therapies for lymphoma - CAR T-cell therapy and the question of cure
Anas Younes et al.
The progress of CLL research: towards targeted therapy
What’s next for rare myelomas?
Benefit of treating smouldering myeloma patients early with lenalidomide & dexamethasone